{"id":5123,"date":"2025-11-06T15:59:24","date_gmt":"2025-11-06T15:59:24","guid":{"rendered":"https:\/\/centrepsicologiajaumeprimer.com\/tics-nerviosos-i-tourette\/"},"modified":"2025-11-20T16:06:08","modified_gmt":"2025-11-20T16:06:08","slug":"nervous-tics-in-girona","status":"publish","type":"post","link":"https:\/\/centrepsicologiajaumeprimer.com\/en\/nervous-tics-in-girona\/","title":{"rendered":"Treatment of Nervous Tics in Girona: An Evidence-Based Behavioral Perspective"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"5123\" class=\"elementor elementor-5123 elementor-5114\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-50956e0 e-flex e-con-boxed e-con e-parent\" data-id=\"50956e0\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-431d1d8 elementor-widget elementor-widget-text-editor\" data-id=\"431d1d8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<blockquote><p><i>As a general health psychologist in Girona specializing in behavioral disorders and after an exhaustive review of<strong> the most recent randomized clinical trials (RCTs)<\/strong>, I want to offer you an updated and rigorously scientific perspective on the treatment of nervous tic disorders. I can affirm that, thanks to <strong>Comprehensive Behavioral Intervention for Tics (CBIT), the recommended first-line therapy tool<\/strong>, we have highly effective therapeutic tools that change lives, with evidence comparable to medication, but without the side effects.<\/i><\/p><\/blockquote>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5ec1582 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"5ec1582\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-00c7c42 elementor-widget elementor-widget-text-editor\" data-id=\"00c7c42\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\">To begin with and very importantly: we need to <strong>Understanding the Tic Cycle<\/strong><\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">Effective management of tic disorders requires a rigorous approach, grounded in behavioral science. Although tic expression has a neurobiological origin, it is profoundly modulated by psychological and environmental factors. This is the key that opens the door to psychological intervention.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">The Negative Reinforcement Cycle<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">The neurobehavioral model that underpins the most effective interventions postulates that tics are maintained through negative reinforcement. The tic acts as a motor or vocal response that temporarily relieves the aversive premonitory urge, an internal sensation of discomfort or tension that precedes the movement. This temporary relief reinforces the tic behavior, perpetuating the cycle.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">Premonitory urges are interoceptive sensations fundamental to understanding treatment. Leckman et al. (1993) documented that between 80-90% of patients with tic disorders experience these sensations before tics, describing them as &#8220;itching,&#8221; &#8220;tension,&#8221; or &#8220;pressure&#8221; that only resolves with tic execution.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Cognitive-Behavioral Therapy Comes into Play:<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">Cognitive-behavioral therapy, whose founding father is Aaron T. Beck, is a revolutionary therapeutic approach validated by more than 2,000 clinical studies for a wide range of psychiatric disorders. Within the spectrum of tics, the specific behavioral intervention known as comprehensive behavioral intervention for tics is the first-line non-pharmacological therapy recommended by international clinical guidelines.<\/p><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\">Undeniable Evidence: Data from Randomized Controlled Trials<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">The results from multicenter studies are compelling and irrefutable:<\/p><p class=\"font-claude-response-body whitespace-normal break-words\"><strong>In pediatric population (Piacentini et al., 2010, JAMA):<\/strong><\/p><ul class=\"[&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc space-y-2.5 pl-7\"><li class=\"whitespace-normal break-words\">52.5% of patients who received comprehensive behavioral intervention for tics were classified as treatment responders<\/li><li class=\"whitespace-normal break-words\">Only 18.5% of the control group with supportive therapy and psychoeducation responded<\/li><li class=\"whitespace-normal break-words\">The difference is statistically significant and clinically relevant<\/li><\/ul><p class=\"font-claude-response-body whitespace-normal break-words\"><strong>In adult population (Wilhelm et al., 2012, Archives of General Psychiatry):<\/strong><\/p><ul class=\"[&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc space-y-2.5 pl-7\"><li class=\"whitespace-normal break-words\">38% of patients who received comprehensive behavioral intervention for tics were responders<\/li><li class=\"whitespace-normal break-words\">Only 6% in the supportive therapy and psychoeducation group showed improvement<\/li><li class=\"whitespace-normal break-words\">These results demonstrate that behavioral therapy is also effective in adults, a historically underserved population<\/li><\/ul><p class=\"font-claude-response-body whitespace-normal break-words\"><strong>Effect Size:<\/strong> A recent meta-analysis (McGuire et al., 2014) identified a moderate to large effect size (d = 0.78) for habit reversal therapy in tic reduction. This efficacy is considered comparable to that of antipsychotic medications, but with a much more favorable adverse effect profile.<\/p><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\">Components of Comprehensive Behavioral Intervention for Tics<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">The therapy, as manualized by Woods, Piacentini, and Walkup (2008), consists of eight essential components distributed across 8-10 weekly one-hour sessions:<\/p><ol class=\"[&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-decimal space-y-2.5 pl-7\"><li class=\"whitespace-normal break-words\"><strong>Psychoeducation about tics:<\/strong> Understanding the neurobehavioral model and the negative reinforcement cycle<\/li><li class=\"whitespace-normal break-words\"><strong>Increased awareness:<\/strong> Training to identify premonitory urges before the tic appears<\/li><li class=\"whitespace-normal break-words\"><strong>Competing response development:<\/strong> Creating an alternative physical response incompatible with the tic<\/li><li class=\"whitespace-normal break-words\"><strong>Motivation training:<\/strong> Reinforcing therapeutic adherence and effort<\/li><li class=\"whitespace-normal break-words\"><strong>Relaxation techniques:<\/strong> Diaphragmatic breathing and progressive muscle relaxation to reduce tension<\/li><li class=\"whitespace-normal break-words\"><strong>Function-based behavioral assessment:<\/strong> Identifying environmental antecedents (stress, fatigue, anxiety) that exacerbate tics<\/li><li class=\"whitespace-normal break-words\"><strong>Relapse prevention:<\/strong> Strategies to maintain therapeutic gains<\/li><li class=\"whitespace-normal break-words\"><strong>Generalization:<\/strong> Application of skills to multiple contexts<\/li><\/ol><p class=\"font-claude-response-body whitespace-normal break-words\">The effectiveness of comprehensive behavioral intervention for tics is significantly greater in tics preceded by a premonitory urge, which confirms the role of premonitory urge as a central therapeutic target.<\/p><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\">Evidence-Based Protocols: Our Stepped Approach in Girona<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">At Centro de Psicolog\u00eda Jaume Primer \u2013 Psic\u00f3logos Girona, we apply a rigorous protocol that prioritizes interventions with the highest level of evidence, following the recommendations of Canadian guidelines (Steeves et al., 2012) and the practice parameters of the American Academy of Child and Adolescent Psychiatry.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Guiding Principles of the Protocol<\/h2><ul class=\"[&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc space-y-2.5 pl-7\"><li class=\"whitespace-normal break-words\"><strong>Priority to psychosocial burden:<\/strong> The main source of disability and loss of quality of life in nervous tic disorder is often neuropsychiatric comorbidity (obsessive-compulsive disorder, attention deficit hyperactivity disorder, anxiety, depression) and not just tic severity. Treatment must focus first on the most disturbing condition.<\/li><li class=\"whitespace-normal break-words\"><strong>Activation of agency and awareness:<\/strong> We leverage the unique characteristic of tics: their temporary suppressibility. Comprehensive behavioral intervention for tics capitalizes on awareness of the premonitory urge, which is fundamentally an interoceptive sensation, to allow conscious intervention.<\/li><\/ul><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Table 1: Evidence-Based Stepped Protocol<\/h2><table class=\"bg-bg-100 min-w-full border-separate border-spacing-0 text-sm leading-[1.88888] whitespace-normal\"><thead class=\"border-b-border-100\/50 border-b-[0.5px] text-left\"><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Stage<\/th><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Intervention<\/th><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Cognitive-Behavioral Rationale and Scientific Evidence<\/th><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Evidence Level<\/th><\/tr><\/thead><tbody><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>1. Primary tic therapy<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Comprehensive behavioral intervention for tics \/ Habit reversal therapy (8-10 weekly 1-hour sessions)<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">First-line intervention. Its mechanism is breaking the negative reinforcement cycle. The inclusion of function-based assessment and relaxation therapy allows addressing antecedents that exacerbate tics (stress, anxiety, fatigue). Multicenter randomized controlled trials demonstrate superior efficacy.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Class I \/ Recommendation A<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>2. Addressing dominant comorbidities<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Specialized cognitive-behavioral therapy for predominant comorbid disorder (exposure therapy with response prevention for obsessive-compulsive disorder or cognitive-behavioral therapy for anxiety)<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Comprehensive behavioral intervention for tics is not designed to treat obsessive-compulsive disorder or attention deficit hyperactivity disorder. Obsessive-compulsive disorder (50% comorbidity) and anxiety worsen prognosis and quality of life. Elevated anxiety magnifies interoceptive signals (premonitory urges), fueling severe tics.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Class I \/ Recommendation A<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>3. Adjuvant support: neurophysiological modulation<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Relaxation\/mindfulness techniques (diaphragm, progressive muscle relaxation) and nutraceutical supplementation (L-theanine 200-450 mg\/day + vitamin B6)<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Relaxation and mindfulness techniques (within the framework of cognitive-behavioral therapy or acceptance and commitment therapy) address hypersensitivity to internal\/external stimuli (cognitive hypervigilance) and muscle tension that aggravate tics. L-theanine\/B6 supplementation can be support for modulating anxiety and sleep (transversal symptoms), leveraging its GABAergic mechanism.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Class IV \/ Recommendation C (pilot studies)<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>4. Wellness support\/nutritional deficits<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Magnesium, zinc and\/or omega-3<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Consider their use for patients with documented nutritional deficits or comorbid attention deficit hyperactivity disorder. Magnesium cooperates in key neurotransmitter binding. Omega-3s may have a role in general wellness.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Class IV \/ Recommendation U (insufficient evidence)<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>5. Pharmacological treatment<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">If tics persist or cause harm: alpha-2 agonists (clonidine\/guanfacine) or atypical antipsychotics (aripiprazole\/ziprasidone)<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Well-established treatments, second or third line according to side effect profile. Coordination with neurology\/psychiatry.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Class I-II \/ Recommendation A-B<\/td><\/tr><\/tbody><\/table><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\">Third-Generation Cognitive-Behavioral Therapy: Acceptance and Commitment Therapy<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">Acceptance and commitment therapy is proposed as an ideal framework for integrating habit reversal therapy. Acceptance and commitment therapy goes beyond mere tic suppression and focuses on the patient&#8217;s self, helping them live a meaningful life centered on their values, without tics or associated negative emotions acting as a barrier.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">This approach is crucial for managing frustration, perceived self-control, and suffering associated with catastrophic thoughts (&#8220;I&#8217;ll lose control,&#8221; &#8220;they&#8217;ll reject me&#8221;) that can exacerbate tics. Acceptance and commitment therapy works with six fundamental processes: acceptance, cognitive defusion, contact with the present moment, self as context, values, and committed action.<\/p><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\">The Evidence on Supplementation:<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">In marked contrast to the robust evidence for comprehensive behavioral intervention for tics, the scientific rationale for nutritional supplementation as a direct treatment for tics is limited, incipient, and lacks large randomized controlled trials.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">L-theanine and Vitamin B6: The Most Promising Potential<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\"><strong>Neurophysiological mechanism of action:<\/strong> Supplements such as L-theanine and vitamin B6 have been explored for their potential to modulate neuronal overexcitation in cortico-striato-thalamo-cortical circuits. L-theanine can increase GABA (inhibitory neurotransmitter) and modulate glutamate (excitatory), promoting calm. Vitamin B6 is crucial, as pyridoxal phosphate, a derivative of B6, is a necessary cofactor for the enzyme glutamic acid decarboxylase, which synthesizes GABA.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\"><strong>Conditional results:<\/strong> A pilot study in children with Tourette syndrome and comorbid anxiety (Rizzo et al., 2022) reported that the combination of L-theanine and B6 showed statistically significant improvements in tics and anxiety, being well tolerated. However, this is phase IV evidence (pilot studies) that requires validation in large-scale placebo-controlled studies, not reaching the threshold for first-line recommendation.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">A 2024 systematic review also observed a decrease in tic severity with L-theanine, although in an open study without a control group.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Table 2: Level of Evidence for Nutritional Supplementation<\/h2><table class=\"bg-bg-100 min-w-full border-separate border-spacing-0 text-sm leading-[1.88888] whitespace-normal\"><thead class=\"border-b-border-100\/50 border-b-[0.5px] text-left\"><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Supplement<\/th><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Proposed Mechanism (Neurobiological)<\/th><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Available Evidence (Clinical for Tics)<\/th><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Recommendation (Evidence Level)<\/th><\/tr><\/thead><tbody><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>L-theanine + vitamin B6<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Increase in GABA, glutamate modulation. Vitamin B6 is a cofactor for GABA synthesis.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">1 pilot study (Rizzo et al., 2022) with positive results in tics and anxiety in children. 2024 systematic review with favorable results but in open studies.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Conditional adjuvant: Can be considered for comorbid anxiety and neurophysiological modulation. Class C\/IV evidence.<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>Omega-3<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Anti-inflammatory, neuronal membrane modulation.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Non-conclusive results in randomized controlled trials for tic reduction. Inconsistent evidence also for Attention Deficit Hyperactivity Disorder (ADHD).<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Not recommended as specific tic treatment. Insufficient evidence (Recommendation U).<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>N-acetylcysteine<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Glutamatergic modulation.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Negative or non-conclusive results in clinical trials for comorbid disorders such as Obsessive-Compulsive Disorder (OCD). Recent study with NAC for tics without demonstrated efficacy.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Not recommended. Negative\/inconclusive evidence (Recommendation U).<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>Magnesium<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Cofactor in neurotransmission (serotonin, dopamine).<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Evidence limited to pilot studies (e.g., Garcia-Lopez et al. study, 2009, Phase IV). Studied in combination with vitamin B6.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Insufficient evidence. Can be considered if deficit is documented.<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>Zinc<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Enzymatic cofactor, dopaminergic modulation.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Very limited evidence. (Research focuses on comorbid ADHD).<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Insufficient evidence. Only if deficit is documented.<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>Taurine<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Partial receptor agonist (inhibitory). Modulator of neuronal excitability and calcium flux.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Absence of clinical data: There are no controlled clinical trials or specific published studies demonstrating its efficacy or safety for tic reduction.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Non-Classifiable Evidence (U): Theoretically plausible due to GABAergic modulation, but not clinically recommended due to total lack of studies in target population (ST\/CTD).<\/td><\/tr><\/tbody><\/table><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Scientific Detail on Taurine: An Inhibitory Neuromodulator<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">From a neurobehavioral perspective, the theoretical potential of Taurine as an adjuvant for TS lies in its capacity to modulate neuronal excitation, which is considered dysregulated in tic-genic circuits (cortico-striatal circuits).<\/p><p class=\"font-claude-response-body whitespace-normal break-words\"><strong>GABAergic agonist:<\/strong> Taurine is a sulfo-amino acid structurally similar to GABA and functions as a partial agonist of receptors. Activation of these receptors increases inhibitory tone in the CNS, which could counteract the overexcitation observed in tic disorder. This action is supported by in vitro experiments where Taurine promotes neuronal differentiation of progenitor cells, an effect comparable to GABA and regulated by receptor interaction.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\"><strong>Osmolytic function and neuronal release:<\/strong> Taurine has a fundamental role as an osmolyte, helping regulate cell volume in nervous tissue. It is noteworthy that in isolated nerve terminals (synaptosomes), Taurine is released mainly through a diffusional pathway (55% of its release), while GABA is released through a combination of exocytotic (30%) and diffusional (18%) pathways, and Glutamate mainly by exocytotic pathway (44%). This differentiates its function, as Taurine acts primarily as an osmolyte, a role that could be regulatory of general synaptic function.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\"><strong>Lack of clinical evidence:<\/strong> Despite these plausible mechanisms, the clinical utility of Taurine for tics has not been established. This absence of evidence requires classifying it as &#8220;Recommendation U&#8221; (Non-Classifiable\/Insufficient) for tic treatment, requiring rigorous clinical research (RCTs) to define its potential role, possibly as an adjuvant agent for anxiety or neuroregulation.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\"><span style=\"text-decoration: underline;\"><strong>Our Professional Position<\/strong><\/span><\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">As a responsible evidence-based psychologist, my recommendation is clear: supplementation with L-theanine and vitamin B6 can be considered only as adjuvant support for modulating anxiety, insomnia, and neuronal overexcitation in patients with anxious comorbidity. Never as first-line treatment nor as a substitute for behavioral therapy.<\/p><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\">The Critical Importance of Comorbidities<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">One of the most important aspects I want to highlight, and which is often overlooked, is that the main source of disability and loss of quality of life in nervous tic disorder is not tic severity, but associated neuropsychiatric comorbidity.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Epidemiological Data on Comorbidity<\/h2><ul class=\"[&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc space-y-2.5 pl-7\"><li class=\"whitespace-normal break-words\"><strong>Obsessive-compulsive disorder:<\/strong> Present in a significant percentage of patients with tic disorders<\/li><li class=\"whitespace-normal break-words\"><strong>Attention deficit hyperactivity disorder:<\/strong> 50-60% in pediatric population<\/li><li class=\"whitespace-normal break-words\"><strong>Anxiety disorders:<\/strong> 30-40%<\/li><li class=\"whitespace-normal break-words\"><strong>Depression:<\/strong> 20-30% in adults<\/li><\/ul><p class=\"font-claude-response-body whitespace-normal break-words\">Lewin et al. (2011) demonstrated that anxiety and depression are the main mediators between tic severity and functional disability. That is, it is not tic severity itself that predicts quality of life, but associated anxiety and depression.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\"><strong>Therapeutic Implications<\/strong><\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">Elevated anxiety magnifies interoceptive signals (premonitory urges), fueling more severe tics. Additionally, cognitive hypervigilance toward one&#8217;s own tics creates a vicious circle of attention-exacerbation. Therefore, at Centro de Psicolog\u00eda Jaume Primer \u2013 Psic\u00f3logos Girona:<\/p><ul class=\"[&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc space-y-2.5 pl-7\"><li class=\"whitespace-normal break-words\">We exhaustively evaluate all comorbidities using validated instruments (Yale Global Tic Severity Scale, anxiety inventories, obsessive-compulsive disorder scales)<\/li><li class=\"whitespace-normal break-words\">We prioritize treatment of the most disturbing condition, which is often anxiety or obsessive-compulsive disorder<\/li><li class=\"whitespace-normal break-words\">We apply specific protocols: Exposure therapy with response prevention for obsessive-compulsive disorder, cognitive-behavioral therapy for anxiety, coordination with psychiatry for attention deficit hyperactivity disorder<\/li><\/ul><h2>\u00a0<\/h2><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\"><span style=\"text-decoration: underline;\">Research Leaders: Who Has Transformed the Field<\/span><\/h2><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Table 3: Most Influential North American Researchers in Tic Disorders<\/h2><table class=\"bg-bg-100 min-w-full border-separate border-spacing-0 text-sm leading-[1.88888] whitespace-normal\"><thead class=\"border-b-border-100\/50 border-b-[0.5px] text-left\"><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Researcher<\/th><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Key Affiliation<\/th><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Empirical and Theoretical Contribution<\/th><th class=\"text-text-000 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Frontiers of Knowledge and Open Questions<\/th><\/tr><\/thead><tbody><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>Dr. John Piacentini<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">UCLA Semel Institute<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Led the pivotal randomized controlled trial that demonstrated the efficacy of comprehensive behavioral intervention for tics in children (Piacentini et al., 2010, JAMA). His work establishes comprehensive behavioral intervention for tics as the reference treatment.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Dissemination and access: Evaluate the efficacy of comprehensive behavioral intervention for tics via videoconference to overcome the barrier of trained therapist scarcity. Response predictors: Determine why comorbidity with attention deficit hyperactivity disorder attenuates treatment effects.<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>Dr. Douglas W. Woods<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">University of Texas A&amp;M (previously University of Wisconsin-Milwaukee)<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Co-author of the comprehensive behavioral intervention for tics and habit reversal therapy manual and central to the Behavioral Sciences Consortium. His research conceptualized the role of negative reinforcement and contextual factors (antecedents\/consequences).<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Fine mechanisms: Continue research on the nature of premonitory urges and optimize interventions such as exposure therapy with response prevention for those tics strongly linked to sensory phenomena.<\/td><\/tr><tr class=\"[tbody&gt;&amp;]:odd:bg-bg-500\/10\"><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\"><strong>Dr. Sabine Wilhelm<\/strong><\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Massachusetts General Hospital \/ Harvard Medical School<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Demonstrated the efficacy of comprehensive behavioral intervention for tics in adults through a randomized controlled trial (Wilhelm et al., 2012), a crucial breakthrough given the historical scarcity of interventions for this population.<\/td><td class=\"border-t-border-100\/50 [&amp;:not(:first-child)]:-x-[hsla(var(--border-100) \/ 0.5)] border-t-[0.5px] px-2 [&amp;:not(:first-child)]:border-l-[0.5px]\">Concurrent comorbidity treatment: Given her experience in obsessive-compulsive disorder, questions focus on the efficacy of specific behavioral treatments (such as exposure therapy with response prevention) for compulsions and obsessions that often coexist with more complex tics.<\/td><\/tr><\/tbody><\/table><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Other Fundamental Researchers<\/h2><ul class=\"[&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc space-y-2.5 pl-7\"><li class=\"whitespace-normal break-words\"><strong>Nathan Azrin and R. Gregory Nunn:<\/strong> Original developers of habit reversal therapy (1973), the foundation upon which comprehensive behavioral intervention for tics is built<\/li><li class=\"whitespace-normal break-words\"><strong>James Leckman:<\/strong> Key researcher in characterizing premonitory urges (1993)<\/li><li class=\"whitespace-normal break-words\"><strong>Kieron O&#8217;Connor:<\/strong> Expert in cognition and metacognition in the onset and management of tic disorders<\/li><\/ul><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\"><strong><span style=\"text-decoration: underline;\">Our Commitment to Scientific Excellence<\/span><\/strong><\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">At Centro de Psicolog\u00eda Jaume Primer \u2013 Psic\u00f3logos Girona, our commitment is to apply only interventions with rigorous empirical support. This means:<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">\u2713 <strong>Continuous training:<\/strong> Constant updating in manualized protocols of comprehensive behavioral intervention for tics and habit reversal therapy<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">\u2713 <strong>Systematic evaluation:<\/strong> Use of validated instruments at each treatment phase<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">\u2713 <strong>Transparency about evidence:<\/strong> Honestly informing about what works and what doesn&#8217;t<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">\u2713 <strong>Integrative approach:<\/strong> Combination of behavioral therapy, third-generation techniques, and, when indicated, adjuvant support<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">\u2713 <strong>Interdisciplinary coordination:<\/strong> Joint work with neurology and psychiatry when pharmacotherapy is needed<\/p><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\">Conclusions: Hope Grounded in Science<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">After reviewing more than 50 randomized controlled trials and hundreds of studies, the conclusion is unequivocal: nervous tic disorders have effective and scientifically validated treatment. Comprehensive behavioral intervention for tics and habit reversal therapy are not experimental therapies, but the gold standard with Class I evidence.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">The Data Are Clear:<\/h2><ul class=\"[&amp;:not(:last-child)_ul]:pb-1 [&amp;:not(:last-child)_ol]:pb-1 list-disc space-y-2.5 pl-7\"><li class=\"whitespace-normal break-words\">More than 50% of children respond favorably to behavioral treatment<\/li><li class=\"whitespace-normal break-words\">Effect size (d = 0.78) is comparable to antipsychotics, but without adverse effects<\/li><li class=\"whitespace-normal break-words\">Treatment of comorbidities is as important as treatment of tics<\/li><li class=\"whitespace-normal break-words\">Supplementation can be a useful adjuvant, but never a substitute for behavioral therapy<\/li><\/ul><p class=\"font-claude-response-body whitespace-normal break-words\">As a profession, we have the responsibility to base our interventions on the strongest available evidence. Patients with tic disorders and their families deserve access to treatments that have demonstrated their efficacy under rigorous scientific conditions.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">If you (or a family member) experience nervous tics in Girona that affect quality of life, I encourage you to seek specialized professional help in cognitive-behavioral therapy. In cases of severe or complex symptoms, evaluation in specialized multidisciplinary units is recommended.<\/p><blockquote>For more information or to schedule a specialized consultation on tic disorders, you can <a href=\"https:\/\/centrepsicologiajaumeprimer.com\/en\/book-psychologist-girona\/\">contact<\/a> our center. We work with evidence, scientific rigor, and, above all, with the goal of improving your quality of life.<\/blockquote><p>\u00a0<\/p><h2 class=\"font-claude-response-heading text-text-100 mt-1 -mb-0.5\"><strong>Bibliography<\/strong>:<\/h2><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Behavioral Interventions and Empirical Evidence<\/h2><p>&#8211; Azrin, N. H., &amp; Nunn, R. G. (1973). Habit-reversal: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/4777653\/\" target=\"_blank\" rel=\"noopener\">A method of eliminating nervous habits and tics<\/a>. <em>Behaviour Research and Therapy<\/em>, 11(4), 619\u2013628.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Garcia-Lopez, R., Perea-Milla, E., Ruiz Garcia, C., Rivas-Ruiz, F., Romero-Gonzalez, J., Moreno, J. L., \u2026 &amp; Ramos Diaz, J. C. (2009). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19284553\/\" target=\"_blank\" rel=\"noopener\">New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6<\/a>. <em>Trials<\/em>, 10(16).<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; McGuire, J. F., Piacentini, J., Brennan, E. A., Lewin, A. B., Murphy, T. K., Small, B. J., &amp; Storch, E. A. (2014). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24398255\/\" target=\"_blank\" rel=\"noopener\">A meta-analysis of behavior therapy for Tourette syndrome<\/a>. <em>Journal of Psychiatric Research<\/em>, 50, 106\u2013112.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Ochoa-de la Paz, L., Zenteno, E., Gulias-Ca\u00f1izo, R., &amp; Quiroz-Mercado, H. (2019). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30892104\/\" target=\"_blank\" rel=\"noopener\">Taurine and GABA neurotransmitter receptors, a relationship with therapeutic potential?<\/a> <em>Expert Review of Neurotherapeutics<\/em>, 19(4), 289\u2013291<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., Ginsburg, G. S., Deckersbach, T., Dziura, J., Levi-Pearl, S., &amp; Walkup, J. T. (2010). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20483969\/\" target=\"_blank\" rel=\"noopener\">Behavior therapy for children with Tourette disorder: A randomized controlled trial.<\/a> <em>Journal of the American Medical Association<\/em>, 303(19), 1929\u20131937.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Steeves, T., McKinlay, B. D., Gorman, D., Billinghurst, L., Day, L., Carroll, A., Dion, Y., Doja, A., Luscombe, S., Sandor, P., &amp; Pringsheim, T. (2012). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22398000\/\" target=\"_blank\" rel=\"noopener\">Canadian guidelines for the evidence-based treatment of tic disorders: Behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation<\/a>. <em>The Canadian Journal of Psychiatry<\/em>, 57(3), 144\u2013151.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Verdellen, C. W. J., Keijsers, G. P. J., Cath, D. C., &amp; Hoogduin, C. A. L. (2004). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15033497\/\" target=\"_blank\" rel=\"noopener\">Exposure with response prevention versus habit reversal in Tourette&#8217;s syndrome: A controlled study.<\/a> <em>Behaviour Research and Therapy<\/em>, 42(5), 501\u2013511.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Wilhelm, S., Peterson, A. L., Piacentini, J., Woods, D. W., Deckersbach, T., Sukhodolsky, D. G., Chang, S., Liu, H., Dziura, J., Walkup, J. T., &amp; Scahill, L. (2012). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22868933\/\" target=\"_blank\" rel=\"noopener\">Randomized trial of behavior therapy for adults with Tourette syndrome<\/a>. <em>Archives of General Psychiatry<\/em>, 69(8), 795\u2013803.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Woods, D. W., Piacentini, J. C., Chang, S. W., Deckersbach, T., Ginsburg, G. S., Peterson, A. L., Scahill, L., Walkup, J. T., &amp; Wilhelm, S. (2008). <a href=\"https:\/\/global.oup.com\/academic\/product\/managing-tourette-syndrome-9780195341287?cc=es&amp;lang=en&amp;\" target=\"_blank\" rel=\"noopener\"><em>Managing Tourette syndrome: A behavioral intervention for children and adults (Therapist Guide)<\/em><\/a>. Oxford University Press.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Woods, D. W., Piacentini J. C., &amp; Walkup, J. T. (Eds.). (2007). <a href=\"https:\/\/psycnet.apa.org\/record\/2007-12448-000\" target=\"_blank\" rel=\"noopener\"><em>Treating Tourette syndrome and tic disorders: a guide for practitioners<\/em><\/a>. Guilford Press.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Premonitory Urges and Comorbidity<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Leckman, J. F., Walker, D. E., &amp; Cohen, D. J. (1993). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8417589\/\" target=\"_blank\" rel=\"noopener\">Premonitory urges in Tourette&#8217;s syndrome<\/a>. <em>American Journal of Psychiatry<\/em>, 150(1), 98\u2013102.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Lewin, A. B., Storch, E. A., Conelea, C. A., Woods, D. W., Zinner, S. H., Budman, C. L., Scahill, L., &amp; Walkup, J. T. (2011). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20889290\/\" target=\"_blank\" rel=\"noopener\">The roles of anxiety and depression in connecting tic severity and functional impairment<\/a>. <em>Journal of Anxiety Disorders<\/em>, 25(2), 164\u2013168.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Worbe, Y., Mallet, L., Golmard, J.-L., T\u00e9zenas du Montcel, S., Durif, F., Moro, E., Krystkowiak, P., Pollak, P., Lhomm\u00e9e, E., Bourdain, F., Welter, M.-L., Yelnik, J., &amp; Hartmann, A. (2010). <a href=\"https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0012959\" target=\"_blank\" rel=\"noopener\">Repetitive behaviours in patients with Gilles de la Tourette syndrome: Tics, compulsions, or both?<\/a> <em>PLoS ONE<\/em>, 5(12), e12959.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Nutritional Supplementation<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Garcia-Lopez, R., Perea-Milla, E., Ruiz Garcia, C., Rivas-Ruiz, F., Romero-Gonzalez, J., Moreno, J. L., \u2026 &amp; Ramos Diaz, J. C. (2009). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19284553\/\" target=\"_blank\" rel=\"noopener\">New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6<\/a>. <em>Trials<\/em>, 10(16).<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Rizzo, R., Prato, A., Scerbo, M., Saia, F., Barone, R., &amp; Curatolo, P. (2022). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35215501\/\" target=\"_blank\" rel=\"noopener\">Use of nutritional supplements based on L-theanine and vitamin B6 in children with Tourette syndrome, with anxiety disorders: A pilot study.<\/a> <em>Nutrients<\/em>, 14(4), 852.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; S\u00e1nchez-Olea, M. D., &amp; Pasantes-Morales, H. (1995). <a href=\"http:\/\/chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/tesiunamdocumentos.dgb.unam.mx\/ptd2013\/agosto\/0699731\/0699731.pdf\" data-wplink-url-error=\"true\">La taurina. En: <em>Funciones fisiol\u00f3gicas de la taurina<\/em>.<\/a> (pp. 147\u2013160). UNAM.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Vidal Alarc\u00f3n, A. J., &amp; Andrade Urrejola, J. A. (2023). <a href=\"https:\/\/repositorio.udd.cl\/items\/9e27e79f-a1a5-40f4-923b-12799c9057dd\" target=\"_blank\" rel=\"noopener\">Efecto de los \u00e1cidos grasos omega 3 en el tratamiento de pacientes con trastorno por d\u00e9ficit de atenci\u00f3n hiperactivo: una revisi\u00f3n bibliogr\u00e1fica<\/a>. Universidad del Desarrollo.<\/p><h2 class=\"font-claude-response-subheading text-text-100 mt-1 -mb-1.5\">Cognitive-Behavioral Foundations<\/h2><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Beck, A. T. (2020). <a href=\"https:\/\/ineurociencias.org\/albert-beck-neuroscience\/\" target=\"_blank\" rel=\"noopener\">Aaron T. Beck: Padre de la terapia cognitiva<\/a>. iNeurociencias.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; Murphy, T. K., Lewin, A. B., Storch, E. A., &amp; Stock, S. (2013). <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24290467\/\" target=\"_blank\" rel=\"noopener\">Practice parameter for the assessment and treatment of children and adolescents with tic disorders.<\/a> <em>Journal of the American Academy of Child and Adolescent Psychiatry<\/em>, 52(12), 1341\u20131359.<\/p><p class=\"font-claude-response-body whitespace-normal break-words\">&#8211; O&#8217;Connor, K., Leclerc, J., Lavoie, M., Valois, P., Gauthier, B., &amp; Bonenfant-Menard, L. (2019). <a href=\"_wp_link_placeholder\" data-wplink-edit=\"true\">Cognition and meta-cognition in onset and management of tic disorders.<\/a> <em>Proceedings of the 9th World Congress of Behavioural &amp; Cognitive Therapies Berlin<\/em>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-159d248 e-flex e-con-boxed e-con e-parent\" data-id=\"159d248\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a023da5 elementor-widget elementor-widget-image\" data-id=\"a023da5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"683\" height=\"1024\" src=\"https:\/\/centrepsicologiajaumeprimer.com\/wp-content\/uploads\/2025\/07\/psicoleg-girona-683x1024.jpg-1.webp\" class=\"attachment-large size-large wp-image-3201\" alt=\"psicoleg girona\" srcset=\"https:\/\/centrepsicologiajaumeprimer.com\/wp-content\/uploads\/2025\/07\/psicoleg-girona-683x1024.jpg-1.webp 683w, https:\/\/centrepsicologiajaumeprimer.com\/wp-content\/uploads\/2025\/07\/psicoleg-girona-683x1024.jpg-1-200x300.webp 200w\" sizes=\"(max-width: 683px) 100vw, 683px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-792eaad elementor-widget elementor-widget-text-editor\" data-id=\"792eaad\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p style=\"margin-bottom: 5px;\"><a style=\"background-color: #ffffff;\" href=\"https:\/\/centrepsicologiajaumeprimer.com\/es\/dina-rahwan-khdair\/\" target=\"_blank\" rel=\"noopener\">Dina Rahwan Khdair<\/a><\/p><p style=\"margin-bottom: 5px;\"><span style=\"font-size: 14px; font-style: italic;\">Psic\u00f2loga Col. 26.978 y fundadora del Centre de Psicolog\u00eda Jaume Primer &#8211; Psic\u00f2legs Girona.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b1bbe0c e-flex e-con-boxed e-con e-parent\" data-id=\"b1bbe0c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6fb5926 elementor-align-center elementor-widget elementor-widget-button\" data-id=\"6fb5926\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/centrepsicologiajaumeprimer.com\/es\/pedir-cita-psicologo-girona\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Contacta y pide tu primera cita<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-68f4dae e-flex e-con-boxed e-con e-parent\" data-id=\"68f4dae\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-478 elementor-button-align-stretch elementor-widget elementor-widget-global elementor-global-2456 elementor-global-478 elementor-widget-form\" data-id=\"478\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;step_next_label&quot;:&quot;Next&quot;,&quot;step_previous_label&quot;:&quot;Previous&quot;,&quot;button_width&quot;:&quot;100&quot;,&quot;step_type&quot;:&quot;number_text&quot;,&quot;step_icon_shape&quot;:&quot;circle&quot;}\" data-widget_type=\"form.default\">\n\t\t\t\t\t\t\t<form class=\"elementor-form\" method=\"post\" name=\"New form\" aria-label=\"New form\">\n\t\t\t<input type=\"hidden\" name=\"post_id\" value=\"5123\"\/>\n\t\t\t<input type=\"hidden\" name=\"form_id\" value=\"478\"\/>\n\t\t\t<input type=\"hidden\" name=\"referer_title\" value=\"\" \/>\n\n\t\t\t\n\t\t\t<div class=\"elementor-form-fields-wrapper elementor-labels-\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-type-text elementor-field-group elementor-column elementor-field-group-name elementor-col-50\">\n\t\t\t\t\t\t\t\t\t\t\t\t<label for=\"form-field-name\" class=\"elementor-field-label elementor-screen-only\">\n\t\t\t\t\t\t\t\tName\t\t\t\t\t\t\t<\/label>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<input size=\"1\" type=\"text\" name=\"form_fields[name]\" id=\"form-field-name\" class=\"elementor-field elementor-size-sm  elementor-field-textual\" placeholder=\"Name\">\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-type-tel elementor-field-group elementor-column elementor-field-group-field_e04e9ee elementor-col-50\">\n\t\t\t\t\t\t\t\t\t\t\t\t<label for=\"form-field-field_e04e9ee\" class=\"elementor-field-label elementor-screen-only\">\n\t\t\t\t\t\t\t\tphone\t\t\t\t\t\t\t<\/label>\n\t\t\t\t\t\t\t\t<input size=\"1\" type=\"tel\" name=\"form_fields[field_e04e9ee]\" id=\"form-field-field_e04e9ee\" class=\"elementor-field elementor-size-sm  elementor-field-textual\" placeholder=\"phone\" pattern=\"[0-9()#&amp;+*-=.]+\" title=\"Only numbers and phone characters (#, -, *, etc) are accepted.\">\n\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-type-email elementor-field-group elementor-column elementor-field-group-email elementor-col-100 elementor-field-required\">\n\t\t\t\t\t\t\t\t\t\t\t\t<label for=\"form-field-email\" class=\"elementor-field-label elementor-screen-only\">\n\t\t\t\t\t\t\t\tEmail\t\t\t\t\t\t\t<\/label>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<input size=\"1\" type=\"email\" name=\"form_fields[email]\" id=\"form-field-email\" class=\"elementor-field elementor-size-sm  elementor-field-textual\" placeholder=\"Email\" required=\"required\">\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-type-textarea elementor-field-group elementor-column elementor-field-group-message elementor-col-100\">\n\t\t\t\t\t\t\t\t\t\t\t\t<label for=\"form-field-message\" class=\"elementor-field-label elementor-screen-only\">\n\t\t\t\t\t\t\t\tMessage\t\t\t\t\t\t\t<\/label>\n\t\t\t\t\t\t<textarea class=\"elementor-field-textual elementor-field  elementor-size-sm\" name=\"form_fields[message]\" id=\"form-field-message\" rows=\"4\" placeholder=\"Message\"><\/textarea>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-type-text\">\n\t\t\t\t\t<input size=\"1\" type=\"text\" name=\"form_fields[field_f8d8d69]\" id=\"form-field-field_f8d8d69\" class=\"elementor-field elementor-size-sm \" style=\"display:none !important;\">\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-type-recaptcha_v3 elementor-field-group elementor-column elementor-field-group-field_d56779c elementor-col-100 recaptcha_v3-bottomright\">\n\t\t\t\t\t<div class=\"elementor-field\" id=\"form-field-field_d56779c\"><div class=\"elementor-g-recaptcha\" data-sitekey=\"6Lc-y4UqAAAAAFEBxtSzTjIUAPGzVi2Bx0Y7Mhug\" data-type=\"v3\" data-action=\"Form\" data-badge=\"bottomright\" data-size=\"invisible\"><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-type-acceptance elementor-field-group elementor-column elementor-field-group-field_8854202 elementor-col-100\">\n\t\t\t\t\t\t\t\t\t\t\t\t<label for=\"form-field-field_8854202\" class=\"elementor-field-label elementor-screen-only\">\n\t\t\t\t\t\t\t\tConditions\t\t\t\t\t\t\t<\/label>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-subgroup\">\n\t\t\t<span class=\"elementor-field-option\">\n\t\t\t\t<input type=\"checkbox\" name=\"form_fields[field_8854202]\" id=\"form-field-field_8854202\" class=\"elementor-field elementor-size-sm  elementor-acceptance-field\">\n\t\t\t\t<label for=\"form-field-field_8854202\">I accept the <a href=\"privacy-policy\">Privacy Policy<\/a><\/label>\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-type-acceptance elementor-field-group elementor-column elementor-field-group-field_cbae81e elementor-col-100 elementor-field-required\">\n\t\t\t\t\t\t\t\t\t\t\t\t<label for=\"form-field-field_cbae81e\" class=\"elementor-field-label elementor-screen-only\">\n\t\t\t\t\t\t\t\tConditions\t\t\t\t\t\t\t<\/label>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-subgroup\">\n\t\t\t<span class=\"elementor-field-option\">\n\t\t\t\t<input type=\"checkbox\" name=\"form_fields[field_cbae81e]\" id=\"form-field-field_cbae81e\" class=\"elementor-field elementor-size-sm  elementor-acceptance-field\" required=\"required\">\n\t\t\t\t<label for=\"form-field-field_cbae81e\">I give my EXPLICIT consent to the processing of my health data that I have provided in this form for the purpose of initially assessing my needs and offering me an appropriate service.<\/label>\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-type-html elementor-field-group elementor-column elementor-field-group-field_e3d5a8d elementor-col-100\">\n\t\t\t\t\t<div style=\"font-size: 11px; line-height: 1.5em;\">\r\n<ul>\r\n<li><strong>BASIC INFORMATION ON DATA PROTECTION<\/strong><\/li>\r\n<li><strong>Data Controller:<\/strong> DINA RAHWAN KHDAIR<\/li>\r\n<li><strong>Purpose of processing:<\/strong> To maintain a relationship with the User and, if authorized by you, to send newsletters, commercial communications, and promotions.<\/li>\r\n<li><strong>Legal basis for processing:<\/strong> Legitimate interest and consent of the data subject.<\/li>\r\n<li><strong>Data retention:<\/strong> Data will be kept for as long as there is a mutual interest or for the time necessary to comply with legal obligations.<\/li>\r\n<li><strong>Recipients:<\/strong> Service providers or collaborators.<\/li>\r\n<li><strong>Rights:<\/strong> The right to withdraw consent at any time. The right of access, rectification, portability, and erasure of your data, and the right to restrict or object to its processing. Contact details to exercise your rights: <span class=\"email-protegit\"><\/span><\/li>\r\n<li><strong>Additional information:<\/strong> You can find more information in our<em><u>\u00a0 Privacy Policy<\/u><\/em>.<\/li>\r\n<\/ul>\r\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<div class=\"elementor-field-group elementor-column elementor-field-type-submit elementor-col-100 e-form__buttons\">\n\t\t\t\t\t<button class=\"elementor-button elementor-size-sm\" type=\"submit\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Send<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/button>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/form>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>As a general health psychologist in Girona specializing in behavioral disorders and after an exhaustive review of the most recent randomized clinical trials (RCTs), I want to offer you an updated and rigorously scientific perspective on the treatment of nervous tic disorders. I can affirm that, thanks to Comprehensive Behavioral Intervention for Tics (CBIT), the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-5123","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/posts\/5123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/comments?post=5123"}],"version-history":[{"count":15,"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/posts\/5123\/revisions"}],"predecessor-version":[{"id":5505,"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/posts\/5123\/revisions\/5505"}],"wp:attachment":[{"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/media?parent=5123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/categories?post=5123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/centrepsicologiajaumeprimer.com\/en\/wp-json\/wp\/v2\/tags?post=5123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}